Tag: gene therapy

All

Latest

CILcare Appoints Aurore Marie Global Head, R&D

CILcare, a CRO specializing in ear disorders, announced the appointment of Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Marie will drive support to production activities at the global level and will serve as a new member of CILcare’s Board, according to the company.

All

Latest

Sonova to Acquire 3.7% Ownership Stake in Sensorion

Sensorion, a clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, announced that Sonova Holding AG will acquire a 3.7% ownership stake in Sensorion by way of subscription to a reserved share capital increase for total gross proceeds of €5 million (USD $6.08 million).

Gene Therapy Used to Restore Hearing and Balance in Mice with Usher Syndrome

In a first-of-its-kind study published in the March 1, 2017 edition of Molecular Therapy, researchers from the National Institute on Deafness and Other Communication Disorders (NIDCD) and Johns Hopkins University School of Medicine showed that gene therapy was able to restore balance and hearing in genetically modified mice that mimic Usher syndrome.

Read More

Partial Hearing and Balance Restored in Deaf Mice Using New Gene-delivery Therapy

Using a novel form of gene therapy, scientists from Harvard Medical School and the Massachusetts General Hospital have managed to restore partial hearing and balance in mice born with a genetic condition that affects both. The new model reportedly overcomes a long-standing barrier to accessing hair cells which have been notoriously difficult to treat with previous gene-delivery techniques.

Read More
Loading